A detailed history of Wells Fargo & Company transactions in Enzo Biochem Inc stock. As of the latest transaction made, Wells Fargo & Company holds 578 shares of ENZ stock, worth $421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
578
Previous 578 -0.0%
Holding current value
$421
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.04 - $1.28 $316 - $389
-304 Reduced 34.47%
578 $0
Q1 2024

May 10, 2024

SELL
$1.21 - $1.5 $508 - $630
-420 Reduced 32.26%
882 $1,000
Q4 2023

Feb 09, 2024

BUY
$1.21 - $1.44 $24 - $28
20 Added 1.56%
1,302 $1,000
Q3 2023

Nov 13, 2023

BUY
$1.3 - $1.87 $9 - $13
7 Added 0.55%
1,282 $1,000
Q2 2023

Aug 15, 2023

BUY
$1.84 - $2.66 $29 - $42
16 Added 1.27%
1,275 $2,000
Q1 2023

May 12, 2023

SELL
$1.0 - $2.51 $2,633 - $6,608
-2,633 Reduced 67.65%
1,259 $3,000
Q4 2022

Feb 13, 2023

BUY
$1.16 - $2.42 $2,825 - $5,895
2,436 Added 167.31%
3,892 $5,000
Q3 2022

Nov 14, 2022

BUY
$2.1 - $2.73 $779 - $1,012
371 Added 34.19%
1,456 $3,000
Q2 2022

Aug 12, 2022

BUY
$2.0 - $3.0 $50 - $75
25 Added 2.36%
1,085 $2,000
Q4 2021

Feb 14, 2022

BUY
$3.17 - $4.09 $3 - $4
1 Added 0.09%
1,060 $4,000
Q3 2021

Nov 15, 2021

SELL
$3.01 - $3.77 $45 - $56
-15 Reduced 1.4%
1,059 $4,000
Q2 2021

Aug 16, 2021

SELL
$2.86 - $3.61 $63,572 - $80,243
-22,228 Reduced 95.39%
1,074 $4,000
Q1 2021

May 13, 2021

SELL
$2.61 - $4.08 $242,333 - $378,819
-92,848 Reduced 79.94%
23,302 $81,000
Q4 2020

Feb 09, 2021

SELL
$1.82 - $2.61 $109,232 - $156,646
-60,018 Reduced 34.07%
116,150 $293,000
Q3 2020

Nov 05, 2020

SELL
$2.02 - $3.02 $63,199 - $94,486
-31,287 Reduced 15.08%
176,168 $371,000
Q2 2020

Aug 13, 2020

SELL
$2.12 - $3.22 $147,783 - $224,462
-69,709 Reduced 25.15%
207,455 $465,000
Q1 2020

May 14, 2020

BUY
$1.82 - $3.87 $504,438 - $1.07 Million
277,164 New
277,164 $701,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $35.6M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.